| [1] |
Vahanian A, Beyersdorf F, Praz F et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7):561-632.
|
| [2] |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines[J]. J Am Coll Cardiol, 2021, 77(4):450-500.
|
| [3] |
Fam NP, von Bardeleben RS, Hensey M, et al. Transfemoral transcatheter tricuspid valve replacement with the EVOQUE system: a multicenter, observational, first-in-human experience[J]. JACC Cardiovasc Interv, 2021, 14(5):501-511.
|
| [4] |
Chen S, Zheng F, Li M, et al. A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation[J]. Ann Transl Med, 2022, 10(11):643.
|
| [5] |
Anwaruddin S, Desai ND, Szeto WY, et al. Self-expanding valve system for treatment of native aortic regurgitation by transcatheter aortic valve implantation (from the STS/ACC TVT Registry)[J]. Am J Cardiol, 2019, 124(5):781-788.
|
| [6] |
Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation[J]. J Am Coll Cardiol, 2017, 70(22):2752-2763.
|
| [7] |
Abdelaziz HK, Wiper A, More RS, et al. Successful transcatheter aortic valve replacement using balloon-expandable valve for pure native aortic valve regurgitation in the presence of ascending aortic dissection[J]. J Invasive Cardiol, 2018, 30(7):E62-E63.
|
| [8] |
El-Gamel A. Transcatheter aortic valve replacement in pure native aortic valve regurgitation: challenging pathology awaiting specialized devices[J]. Aorta (Stamford), 2021, 9(2):56-59.
|
| [9] |
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study[J]. Lancet, 2006, 368(9540):1005-1011.
|
| [10] |
Pan W, Zhou D, Cheng L, et al. Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population: Implications for transcatheter aortic valve replacement[J]. Int J Cardiol, 2015, 201:547-548.
|
| [11] |
齐喜玲, 许海燕, 刘庆荣, 等. 中国老年退行性心脏瓣膜病住院患者诊疗现状分析[J]. 中国循环杂志, 2019, 34(8):771-776.
|
| [12] |
Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II Survey[J]. Circulation, 2019, 140(14):1156-1169.
|
| [13] |
Huded CP, Allen KB, Chhatriwalla AK. Counterpoint: challenges and limitations of transcatheter aortic valve implantation for aortic regurgitation[J]. Heart, 2021, 107(24):1942-1945.
|
| [14] |
Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study[J]. JACC Cardiovasc Interv, 2017, 10(10):1048-1056.
|
| [15] |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经导管主动脉瓣置换术中国专家共识(2020更新版)[J]. 中国介入心脏病学杂志, 2020, 28(6):301-309.
|
| [16] |
龙愉良, 潘文志, 金沁纯, 等. 快速起搏下释放自膨胀式人工主动脉瓣的安全性及有效性——单中心经验[J]. 中国介入心脏病学杂志, 2018, 26(11):601-605.
|
| [17] |
Ng VG, Khalique OK, Nazif T, et al. Treatment of acute aortic insufficiency with a dedicated device[J]. JACC Case Rep, 2021, 3(4):645-649.
|